Mental Matters

Health & Wellness

Woman using tissue for nosebleed while sitting on couch

Symptoms of Hereditary Haemorrhagic Telangiectasia

The symptoms of hereditary haemorrhagic telangiectasia (HHT) are highly variable in presentation, severity, and age of onset. This rare blood vessel disorder causes weak connections between arteries and veins. These can bleed or burst easily. Some people have only mild symptoms for years, while others face serious problems. That’s why it’s so important to understand all possible signs of this condition. Early detection can lead to better treatment and fewer risks. Nosebleeds (Epistaxis) Nosebleeds are the most common and often first symptom of HHT. Around 90% of people with this condition get them. They happen because of tiny, weak blood vessels inside the nose. These break easily from dry air, small bumps, or even during sleep. What to expect: For many, frequent nosebleeds affect their daily lives. They may feel embarrassed or need medical care if it becomes too much. Skin and Mouth Lesions (Telangiectases) Small red or purple spots can show up on the skin or inside the mouth. These are clusters of weak blood vessels close to the surface. Where they appear: These spots usually don’t hurt. They may bleed if scratched, but most of the time, people worry more about how they look. Their presence also helps doctors confirm the diagnosis. Gastrointestinal Bleeding As people with HHT get older, they may develop weak blood vessels in the stomach or intestines. These can break and cause slow, hidden bleeding. Common signs: Visible bleeding is rare, but the damage builds up over time. It’s more common in people over 40 and in HHT type 2. Often, doctors spot it during blood tests. Lung AVMs (Pulmonary Arteriovenous Malformations) In about half of HHT patients, abnormal vessels form in the lungs. These let blood skip past the lungs’ oxygen exchange system, causing problems. Symptoms include: The biggest danger is a paradoxical embolism. This is when clots or germs go through the lungs and reach the brain, leading to stroke or brain infection. Treatment often includes embolisation, a simple procedure that blocks the faulty vessels. Brain AVMs and Serious Complications Brain AVMs are less common but very dangerous. They can cause strokes, seizures, or nerve damage. They might be present at birth and not show up until a crisis. Warning signs: These are more likely in kids or young adults with the ENG gene (HHT type 1). Doctors usually recommend MRI scans, especially in families with known cases. Hepatic AVMs (Liver Involvement) AVMs in the liver might not show signs at first. Over time, they can cause serious issues, especially in HHT type 2. What to look for: Doctors often find these during scans for other reasons. Severe cases may need a liver transplant, but most can be managed with careful care. Spinal AVMs and Rare Effects Spinal AVMs are uncommon but can cause big problems, especially in children. Possible symptoms: If these signs appear, doctors use spine MRIs to check for problems. Tiredness and Anaemia Ongoing bleeding—whether from the nose or stomach—can lead to iron-deficiency anaemia. This makes people feel weak and out of breath. Symptoms include: Iron pills or transfusions can help. But managing the bleeding is the best way to feel better over time. Variation in Symptoms Between Individuals Not everyone with HHT has the same experience. Some get only light nosebleeds. Others may need regular hospital care. Things that affect how bad symptoms are: Hepatitis A and HHT Risk Comparison While Hepatitis A mainly affects the liver and spreads through food or water, HHT impacts blood vessels throughout the body. Yet both conditions can lead to serious health issues if untreated. It’s important to manage both early and effectively. In patients with HHT, liver health is already at risk, so avoiding infections like Hepatitis A is also important. In Summary The symptoms of hereditary haemorrhagic telangiectasia range from mild bleeding to life-threatening AVMs in key organs. Nosebleeds are usually the first sign, but issues can arise in the lungs, brain, liver, and more. Early diagnosis and ongoing care are key to a better life. Just like with Hepatitis A, tracking symptoms and acting early helps avoid long-term damage. [Next: Treatment of Hereditary Haemorrhagic Telangiectasia →]

Symptoms of Hereditary Haemorrhagic Telangiectasia Read More »

Doctor preparing injectable medication for vascular disorder treatment

Treatment of Hereditary Haemorrhagic Telangiectasia

Treatment of Hereditary Haemorrhagic Telangiectasia (HHT) focuses on managing bleeding, preventing complications from AVMs, and improving quality of life. Although there is no cure, modern treatments have greatly improved outcomes. Because HHT affects many organs, care usually involves a team of experts. This team may include ENT doctors, lung and liver specialists, geneticists, and radiologists. 1. Managing Nosebleeds (Epistaxis) Frequent nosebleeds are often the first sign of HHT. Treatment options range from simple home care to surgery. a) Moisturising and HumidificationUsing saline sprays or gel can keep nasal passages moist. A humidifier helps, especially in dry weather or heated rooms. b) Nasal MedicationsTranexamic acid may reduce bleeding by helping clots form. In some centres, doctors apply bevacizumab—a drug that slows blood vessel growth—directly to the nose. c) CauterisationDoctors can seal bleeding vessels using chemicals (like silver nitrate) or heat. These treatments may need to be repeated. d) Laser TreatmentLasers such as Nd:YAG or KTP target abnormal blood vessels while sparing healthy tissue. Results are often good, but bleeding may return. e) SeptodermoplastyThis surgery replaces damaged nasal lining with a skin graft. It’s used when other treatments fail. f) Young’s ProcedureAs a last resort, doctors may close the nostrils to stop airflow and protect vessels. This method almost always stops nosebleeds but affects smell and breathing. 2. Treating Gut Bleeding Bleeding from the stomach or intestines is often hidden but can cause serious anaemia. a) Iron SupplementsMild cases may need only oral iron. In tougher cases, iron is given through a vein. b) EndoscopyDoctors use a method called argon plasma coagulation (APC) during endoscopy to treat bleeding vessels. This may be needed more than once. c) Hormone TherapyHormones like oestrogen and progesterone were once used to reduce bleeding. Today, they’re used less often due to limited benefits and possible side effects. d) Antiangiogenic MedicationsBevacizumab, used through a vein or nose, can reduce severe or stubborn bleeding. However, availability varies by country. 3. Lung AVM Treatment | Treatment of Hereditary Haemorrhagic Telangiectasia Lung AVMs can cause strokes or brain infections. Treating them early is key. a) EmbolisationThis is the best option for most lung AVMs. Doctors insert tiny plugs or coils to block abnormal vessels. The procedure is safe and works well. b) MonitoringPeople need follow-up scans every 3–5 years, or sooner if symptoms return. Bubble echocardiography is used to check for new or persistent AVMs. c) Preventing InfectionsPatients with untreated or partial lung AVMs may need antibiotics before dental or surgical procedures. This lowers the risk of infection reaching the brain. 4. Brain AVM Management Brain AVMs may cause no symptoms or lead to serious problems like seizures or bleeding. a) Watchful WaitingDoctors may monitor small, symptom-free AVMs, especially if surgery is risky. b) SurgeryIf safe, surgeons may remove AVMs entirely. c) EmbolisationLike in the lungs, embolisation can shrink brain AVMs or prepare them for surgery. d) Focused Radiation (Radiosurgery)For small, deep AVMs, doctors use precise radiation (such as Gamma Knife). It works slowly, often over 2–3 years. 5. Treating Liver AVMs Liver AVMs often cause no symptoms. But in severe cases, they may lead to heart failure or bleeding issues. a) MedicinesDiuretics may reduce swelling caused by fluid retention. Bevacizumab may help lower blood flow through the liver in some people. b) Liver TransplantIf other treatments fail, a transplant may be needed. For the right patients, results are usually good. 6. Anaemia and Blood Loss | Treatment of Hereditary Haemorrhagic Telangiectasia Constant bleeding can lead to anaemia, which must be managed over time. a) Iron TherapyOral or IV iron helps restore levels, depending on how severe the loss is. b) Blood TransfusionsUsed in severe or emergency cases. c) Stimulating Red Blood CellsIn rare cases, doctors use medication to help the body make more red blood cells, especially when iron alone isn’t enough. 7. Targeted and Experimental Treatments New treatments are being developed to address the root causes of HHT. Some patients with HHT may even be misdiagnosed with Hepatitis A due to overlapping liver-related symptoms, such as fatigue, poor appetite, or abdominal pain. However, targeted imaging and genetic testing can clearly separate the two conditions. 8. Genetic Counselling and Family Testing HHT runs in families, so genetic counselling is very important. Once a gene mutation is found, other family members can be tested. 9. Team-Based Long-Term Care | Treatment of Hereditary Haemorrhagic Telangiectasia Because HHT affects many organs, patients often need a team of specialists. This team may include: HHT centres of excellence offer coordinated care, access to research, and long-term follow-up to help patients live full lives. In Summary Treatment of hereditary haemorrhagic telangiectasia focuses on stopping bleeding, managing AVMs, and correcting anaemia. It also prevents long-term damage across the body. With regular care and support from specialists, many people with HHT live active, healthy lives. Ongoing research into targeted treatments, including for conditions like Hepatitis A that may resemble some symptoms, continues to improve patient outcomes. [Next: Complications of Hereditary Haemorrhagic Telangiectasia →]

Treatment of Hereditary Haemorrhagic Telangiectasia Read More »

Doctor preparing medication for complications related to hereditary haemorrhagic telangiectasia

Complications of Hereditary Haemorrhagic Telangiectasia

Hereditary haemorrhagic telangiectasia (HHT) can cause a wide range of serious complications. These depend on which organs are affected and how severe the bleeding is. Since HHT impacts blood vessels throughout the body, problems may arise in the skin, nose, brain, lungs, liver, and gut. For some people, the symptoms are mild. For others, they may lead to major health emergencies. Knowing about these complications helps with early treatment, regular check-ups, and better outcomes. 1. Chronic Anaemia Iron-deficiency anaemia is one of the most common problems in HHT. It’s usually caused by frequent nosebleeds and slow bleeding from the gut. If left untreated, it can cause: To treat anaemia, many people need regular iron supplements. Some may need iron through a vein or blood transfusions. If ignored, anaemia can worsen and lead to heart problems. 2. Lung AVMs and Hepatitis A-Like Symptoms Pulmonary arteriovenous malformations (PAVMs) are abnormal blood vessel connections in the lungs. They allow blood to skip the normal oxygen-filtering process. This can lead to: Serious problems include: Doctors often treat PAVMs with embolisation, a procedure to block abnormal vessels. People with PAVMs may also need antibiotics before dental work or surgery to prevent infection spreading to the brain. 3. Brain AVMs and Stroke Risk About 10–20% of people with HHT—especially those with type 1—have arteriovenous malformations in the brain. These brain AVMs can remain silent or suddenly rupture, causing: Early MRI scans can find these AVMs before they cause harm. Treatments may include surgery, embolisation, or focused radiation depending on the size and location. 4. Liver AVMs and Heart Failure Liver AVMs are more common in people with HHT type 2. While they often go unnoticed at first, they can lead to: If these problems become severe, a liver transplant may be the only long-term solution. Regular liver checks help prevent lasting damage. 5. Spinal AVMs Spinal AVMs are rare but dangerous. They can press on the spinal cord and cause: These problems often appear in children with HHT. MRI scans and urgent surgery or embolisation are needed to avoid permanent nerve damage. 6. Digestive Bleeding Small red spots (telangiectases) in the gut can bleed without being noticed. Over time, this can lead to iron-deficiency anaemia or: Bleeding tends to get worse with age, especially after 40. Doctors use scopes and tools like argon plasma coagulation to stop bleeding during procedures. 7. Risks During Pregnancy Pregnancy adds extra risks for women with HHT. Hormone changes and increased blood flow can make AVMs more likely to rupture. Possible complications include: To stay safe, women should get checked for lung and brain AVMs before pregnancy. A team of doctors should follow them closely throughout pregnancy and delivery. 8. Emotional and Social Effects HHT also affects mental health and daily life. People may feel: Support groups, counselling, and educating friends or colleagues can help. Emotional support improves both coping and treatment success. 9. Delays in Diagnosis HHT is often missed or mistaken for other issues, like frequent nosebleeds or unexplained anaemia. These delays may cause: Training healthcare workers to recognise HHT signs is vital. Fast referral to HHT centres can prevent complications and improve care. 10. Hepatitis A Confusion and Diagnostic Challenges Some symptoms of HHT, such as fatigue, low appetite, or gut bleeding, may resemble those of Hepatitis A or other liver issues. This overlap can sometimes delay correct diagnosis. However, blood tests and imaging studies usually help distinguish between the two. In Summary Hereditary haemorrhagic telangiectasia can affect nearly every part of the body. From lungs and brain to liver and spine, its complications can be life-threatening if ignored. Chronic bleeding, anaemia, and the emotional toll also add to the burden. But with early diagnosis, regular checks, and proper treatment, many of these problems can be avoided or reduced. Timely care greatly improves both survival and quality of life. [Next: Prevention of Hereditary Haemorrhagic Telangiectasia →]

Complications of Hereditary Haemorrhagic Telangiectasia Read More »

Genetic counselling and family screening for hereditary haemorrhagic telangiectasia prevention

Prevention of Hereditary Haemorrhagic Telangiectasia

The prevention of hereditary haemorrhagic telangiectasia (HHT) is not straightforward, since the condition is genetic and passed from parent to child. This means it cannot be stopped with vaccines, lifestyle changes, or diet. However, many steps can help prevent the serious effects of the disease. These include genetic counselling, family screening, early treatment, and regular health checks. These tools help reduce the risk of major health problems. Genetic Counselling and Planning for Families HHT happens due to changes in specific genes—ENG, ACVRL1, or SMAD4. That’s why genetic counselling is very important. A child of someone with HHT has a 50% chance of inheriting the condition, no matter their sex. Couples who know they carry HHT may choose to: Genetic counselling gives families the facts they need. It helps them prepare for early checks if a child might have HHT. Testing At-Risk Family Members Early Once a gene change is found in one family member, close relatives (like children, siblings, or parents) can get tested too—even if they feel fine. Early testing helps in many ways: Children can be tested from birth if the gene is known. This is especially helpful when brain or spinal AVMs might appear early in life. Screening and Regular Health Checks Even people with no symptoms should get checked for AVMs, which can form silently in key organs. Common screening tests include: a) Lung AVMs b) Brain AVMs c) Liver AVMs These checks help find problems early—before they lead to stroke, heart failure, or other dangers. Preventing Bleeding From HHT For those with HHT, it’s key to reduce bleeding from the nose, skin, or gut. Helpful steps include: ENT doctors may also use laser therapy or special nose sprays to control bleeding and avoid hospital stays. Avoiding Infections and Clots Lung AVMs can let germs or clots skip the lung filter and go straight to the brain. This can cause brain abscess or stroke. To prevent that: These steps are especially vital for children or adults with untreated AVMs in the lungs. Planning a Safe Pregnancy Pregnancy brings more blood flow and hormone changes, which may make AVMs worse. To stay safe, women with HHT should: With good planning and teamwork, most women with HHT can have safe pregnancies and healthy babies. Preventing Emotional Stress and Isolation HHT affects more than the body. Many people feel anxious or left out due to frequent nosebleeds or visible skin marks. Support includes: Mental health experts help patients feel stronger and more confident while living with HHT. Hepatitis A Education for Doctors and the Public Many people with HHT wait years before getting the right diagnosis. That’s why more education is essential. Key actions include: When doctors recognise the signs early, families can be tested and treated sooner. Future Prevention and Research Researchers are working on new ways to stop HHT from getting worse—or even starting at all. Some new drug trials are testing: As science improves, we may one day prevent AVMs and telangiectases from forming altogether. In Summary Right now, there’s no way to completely prevent hereditary haemorrhagic telangiectasia. But there are strong tools to stop its worst effects. These include genetic testing, early diagnosis, family screening, and regular checks for AVMs. Treating bleeding early and supporting mental health also make a big difference. With a full care plan, people with HHT can live safer, healthier lives. [Next: Outlook for Hereditary Haemorrhagic Telangiectasia →]

Prevention of Hereditary Haemorrhagic Telangiectasia Read More »

Doctor discussing long-term care and dietary guidance with a mother and daughter

Outlook for Hereditary Haemorrhagic Telangiectasia

The outlook for hereditary haemorrhagic telangiectasia (HHT) has greatly improved in recent years. Better awareness, early genetic testing, and improved treatments have all made a difference. Although there is no cure, most people with HHT can live full and active lives. The long-term outcome depends on how early problems are found, how often bleeding happens, and whether patients can access specialist care. Quality of Life and Life Expectancy Most people with HHT can live a normal life span, especially if they don’t have serious organ problems. Those with only mild symptoms—such as nosebleeds or small skin spots—can often manage well with lifestyle changes, outpatient visits, and iron supplements. However, some aspects of HHT can affect quality of life, such as: The good news is that with proper care and emotional support, these issues can be managed. Many people with HHT go on to study, work, travel, and raise families with minimal disruption. Early Diagnosis Improves Outcomes Catching HHT early makes a big difference. When arteriovenous malformations (AVMs) in the lungs, brain, or liver are found before symptoms appear, they can often be treated or monitored. This helps prevent serious complications. For example: Routine checks, especially for people known to carry the HHT gene, are key to staying healthy. Managing HHT with Treatment Many symptoms of HHT respond well to treatment. New methods and medicines are improving outcomes all the time. Some of the most effective treatments include: People with HHT benefit most when treated at clinics that specialise in the condition. These centres provide expert care, education, and quick support if problems come up. Complications That Can Affect Prognosis While many people live well with HHT, complications can occur—especially if the condition goes untreated. Some of the more serious issues include: People with many AVMs, or those without access to good care, may face worse outcomes. This is especially true in places where HHT is not well understood or diagnosed. Pregnancy and HHT Most women with HHT have healthy pregnancies. However, pregnancy puts extra stress on the heart and blood vessels. That’s why screening for AVMs in the lungs or brain is important before pregnancy. With proper planning and care from both obstetric and HHT specialists, most women can safely give birth. But without diagnosis, there is a risk of bleeding or blood clots during pregnancy or delivery. Mental Health and Daily Life Living with a long-term condition like HHT can be emotionally challenging. Some people may feel anxious about sudden nosebleeds, worry about their children’s health, or feel overwhelmed by medical visits. However, mental health improves when: Supportive environments and education help people with HHT feel more in control and less isolated. Why Specialist Care Matters One of the biggest factors in a good outcome is having access to expert care. People who live near HHT centres or teams trained in managing the condition tend to do better. These centres help with: In contrast, people in areas where HHT is not recognised may face: International groups are working hard to improve care everywhere. Their goals include better doctor training, clearer care guidelines, and more support for families. Looking to the Future Research is bringing hope for better treatments—and maybe one day, prevention. Scientists are exploring gene therapy, new drugs that control bleeding, and ways to spot AVMs earlier using imaging and AI. These breakthroughs could lead to faster diagnosis and fewer complications. For families affected by HHT, this brings real hope that the condition can be better controlled—or even cured—in the future. In Summary The outlook for people with hereditary haemorrhagic telangiectasia is positive—especially when the condition is diagnosed early and managed with specialist care. Most people can live long, healthy lives, even with occasional complications. As awareness grows and treatments improve, the future for people living with HHT looks brighter than ever. [Next: Back to Overview →]

Outlook for Hereditary Haemorrhagic Telangiectasia Read More »

Illustration of an inflamed liver surrounded by hepatitis C virus particles

Hepatitis C

Hepatitis C is a viral infection that primarily affects the liver, causing both acute and chronic inflammation that may progress to cirrhosis, liver failure, or hepatocellular carcinoma if left untreated. Transmitted mainly through blood-to-blood contact, hepatitis C often develops silently, with many people remaining unaware of their infection for years or even decades. Unlike hepatitis A and B, there is no vaccine for hepatitis C, but modern antiviral therapies offer a cure for most individuals. This infection remains a serious global health issue. Over 58 million people live with chronic hepatitis C virus (HCV) infection worldwide. Each year, around 1.5 million new cases are reported. The hepatitis C virus is a single-stranded RNA virus from the Flaviviridae family. It has several different genotypes, which vary by region and respond differently to treatment. The most common are genotypes 1, 2, and 3. Genotype 1 is the most widespread and was once the hardest to treat. A Silent Infection with Serious Consequences Hepatitis C is often called a “silent” disease because many people don’t show symptoms during the early stages. Only 20–30% of newly infected individuals feel ill, and symptoms—like fatigue, fever, or stomach discomfort—are usually mild. Because of this, many infections are not diagnosed until liver damage is already present. The virus spreads mainly through blood-to-blood contact. In wealthier countries, the most common way it spreads is through sharing needles or injecting equipment among people who use drugs. However, there are other important ways hepatitis C is transmitted, including: It’s important to know that hepatitis C is not spread through casual contact. You cannot get it from hugging, kissing, or sharing food or drinks. However, people living with HCV should take care not to expose others to their blood. This includes covering any wounds and avoiding shared use of razors or toothbrushes. Chronic Hepatitis C and Global Elimination Goals One of the biggest dangers of hepatitis C is its slow but serious damage to the liver. Around 75–85% of people who catch the virus develop chronic hepatitis C. This increases their risk of liver scarring (fibrosis), cirrhosis, and even liver cancer. These complications often take 10 to 30 years to appear, depending on things like alcohol use, other infections (like HIV or hepatitis B), obesity, or age at infection. In response to the growing threat, global health agencies are working to eliminate hepatitis C as a public health problem. The World Health Organization has set bold targets: a 90% drop in new infections and a 65% drop in deaths by 2030. Achieving these goals depends on raising awareness, improving testing, and making sure people can access the direct-acting antiviral (DAA) medicines that now cure over 95% of cases. In Summary Hepatitis C is a blood-borne virus that can quietly cause serious liver disease if left untreated. Many people don’t know they are infected until years later. Fortunately, most cases can now be cured with safe and effective medication. Stopping the spread of hepatitis C depends on prevention, early testing, and access to treatment. These steps are essential for protecting individuals and easing the burden on health systems worldwide. [Next: Causes of Hepatitis C →]

Hepatitis C Read More »

Illustration showing hepatitis C virus attacking the liver inside the human body

Causes of Hepatitis C

The causes of hepatitis C are exclusively linked to transmission of the hepatitis C virus (HCV) through blood-to-blood contact. Unlike hepatitis A, which spreads through contaminated food or water, or hepatitis B, which spreads through bodily fluids including sexual contact, the causes of hepatitis C mainly involve direct exposure to infected blood. This makes it both preventable and manageable with proper medical care and harm-reduction practices. The hepatitis C virus is a small RNA virus that belongs to the Flaviviridae family. It targets liver cells and, without treatment, can cause long-term inflammation and serious liver damage. Unfortunately, the virus is very good at causing chronic infection. In fact, around 85% of people who get infected don’t clear it on their own. That’s why hepatitis C is one of the leading causes of chronic viral hepatitis across the world. Hepatitis C from Injecting Drug Use and Unsafe Healthcare The most common way people get hepatitis C is by sharing needles or injecting equipment. People who inject drugs are at high risk, especially where sterile supplies and education are lacking. Even one shared needle is enough to spread the virus. In many wealthier countries, this remains the top cause of infection. Studies show that up to 90% of long-term injection drug users carry hepatitis C. It’s not just needles that carry risk—shared filters, water, or even tourniquets can also be sources of infection. Unsafe medical or dental practices are another major cause. In some countries, people still get infected through poorly sterilised instruments, blood transfusions, or surgical tools. This usually happens when clinics don’t follow proper safety measures—like sterilising equipment, using gloves, or testing blood before transfusions. These situations are still common in many low- and middle-income countries. Hepatitis C from Blood Products, Childbirth, and Work Exposure Before the early 1990s, hepatitis C was often spread through blood transfusions and organ transplants. Screening of blood donors only began in the UK in 1991. People who had transfusions or transplants before this time—especially those treated for conditions like haemophilia—may have been infected unknowingly. Today, blood screening is standard, but in some places, poor oversight still puts people at risk. Mothers with hepatitis C can also pass the virus to their babies. This is called vertical transmission. The risk is low—about 5–6%—but it increases if the mother also has HIV or a high amount of the virus in her blood. The infection usually happens during childbirth, not pregnancy. Breastfeeding is safe in most cases, unless the mother’s nipples are cracked or bleeding. Healthcare workers also face risk, mostly through needlestick injuries or accidental exposure to blood. Though the chance of infection from a single needle prick is under 2%, it’s still a concern, especially in busy hospitals or emergency settings. Protective gear, training, and clear safety procedures are essential. Other Causes: Sexual Contact, Tattoos, and Shared Items Hepatitis C is not usually spread through sex, but it can happen—especially among men who have sex with men, or people with HIV. Risk also increases with rough sex, the presence of other STIs, or having multiple partners. While the chance of infection in a monogamous relationship is very low, people with high-risk sexual behaviour should consider getting tested. Getting a tattoo or piercing with non-sterile tools can also spread hepatitis C. This risk is highest in unregulated places, like prisons or informal salons. Even sharing razors, toothbrushes, or other personal items that might carry tiny amounts of blood can be risky. However, in professional shops that follow strict hygiene rules, the risk is very low. People should always make sure single-use needles and sterilised tools are used. At home, casual contact doesn’t spread hepatitis C. Hugging, kissing, or sharing dishes is safe. But if someone in the household has hepatitis C, it’s wise to avoid sharing sharp objects like nail clippers or razors. Accidents involving blood should be cleaned carefully using gloves and disinfectants. Less Common and Rare Routes of Hepatitis C Infection Other infections, like HIV or hepatitis B, can increase the chance of getting hepatitis C. For example, people with HIV are more likely to get hepatitis C through sex or drug use. Also, they may develop liver disease faster and need more complex treatment. There are also a few rare ways people can become infected. In some dialysis units, if equipment isn’t cleaned properly, patients may be exposed. Traditional practices like scarification or blood rituals can also be risky. Even snorting drugs through shared straws may carry risk if blood is present in the nasal passages. In care homes, using glucose monitors or finger-prick devices without single-use lancets has also caused infections in rare cases. In Summary All causes of hepatitis C involve contact with infected blood. Whether through shared needles, poor medical hygiene, or other risky practices, these routes are largely preventable. Better education, access to sterile tools, and safer healthcare practices can greatly reduce new infections. As global awareness and treatment access improve, stopping the spread of hepatitis C becomes more achievable. Still, prevention is the simplest and most effective way to avoid the serious health problems this virus can cause. [Next: Diagnosis of Hepatitis C →]

Causes of Hepatitis C Read More »

Hepatitis C blood test sample held by gloved hand over lab results

Diagnosis of Hepatitis C

The diagnosis of hepatitis C is a multi-step process that begins with identifying individuals at risk of exposure, followed by laboratory testing to confirm the presence of the virus and assess the degree of liver involvement. Since many people with hepatitis C do not show symptoms for years, early detection is vital. Without timely diagnosis, serious problems like cirrhosis or liver cancer may occur. Catching the virus early also allows for effective treatment. Today’s antiviral medicines can cure more than 95% of cases. Who Should Get Tested for Hepatitis C? Because symptoms often don’t appear, testing focuses on people with known risk factors. You should get tested if you: In many countries, people aged 18–79 are now advised to get tested at least once. Pregnant women are also screened during routine care. This approach helps identify more cases early—especially in those with other infections like Hepatitis A. First Step: Antibody Screening Test The first test for hepatitis C checks for antibodies (anti-HCV) in your blood. A positive result means you’ve been exposed to the virus at some point. However, this test can’t tell if the infection is active or has cleared. You could also get a rare false-positive. So, a second test is always needed to confirm. Confirming Infection: HCV RNA (PCR Test) If the antibody test is positive, a PCR test comes next. This checks for hepatitis C RNA (the virus’s genetic material) in the blood. This test: A positive PCR result means active infection. A negative result after a positive antibody test means your body likely cleared the virus naturally. Understanding the Virus Type: HCV Genotyping After confirming an active infection, a genotyping test may be done. This finds out which strain of the hepatitis C virus you have. There are seven main types (genotypes): New treatments work well across most types, but genotyping can still help decide treatment duration or drug choice, especially under specific national guidelines. Liver Function Tests to Check for Damage Doctors also run blood tests to see how well your liver is working. These tests include: These results help doctors check if liver damage has already begun—sometimes even in people who feel fine or only had Hepatitis A in the past. Hepatitis A History and Liver Damage in Hepatitis C After confirming infection, doctors need to assess how much liver damage has occurred. This helps determine how soon treatment should begin. There are three main ways to do this: FibroScan (Transient Elastography) This painless, non-invasive test uses sound waves to check how stiff the liver is. Stiffness usually means scarring or cirrhosis. It’s quick and now widely used instead of liver biopsies. Liver Biopsy In some cases, a small piece of the liver is removed and examined under a microscope. This used to be the gold standard, but it’s now less common. Biopsies are used when other tests give unclear results. Blood Test Panels Simple blood-based tests like APRI or FIB-4 scores use enzyme and platelet counts to estimate liver scarring. These are especially useful in clinics with fewer resources. Other Blood Tests for Related Conditions Doctors also screen for other infections or problems that may affect treatment. Tests may include: Women of childbearing age may also be tested for pregnancy. Some treatments for hepatitis C—and Hepatitis A if co-infected—are unsafe during pregnancy. Imaging Tests to Spot Liver Cancer If liver damage is advanced, doctors use imaging to look for cancer or other liver problems. Tests include: People with cirrhosis need an ultrasound every six months. This helps catch liver cancer early, when it is still treatable. Rapid Tests in the Field In some areas, especially those with limited healthcare access, rapid tests can help screen large groups. These tests use a finger-prick or oral swab and show results in minutes. While they can’t confirm infection, they are a quick way to spot people who need further testing—especially in places where Hepatitis A outbreaks are common. In Summary Diagnosing hepatitis C starts with an antibody test and is confirmed by checking for viral RNA. After that, doctors assess the virus type, liver health, and whether any other infections or conditions are present. This full picture guides treatment choices and helps prevent serious problems. Since many people with hepatitis C don’t feel sick until their liver is badly damaged, early testing—especially in those who’ve had Hepatitis A or other risks—is key to starting a cure before it’s too late. [Next: Symptoms of Hepatitis C →]

Diagnosis of Hepatitis C Read More »

Medical illustration showing liver symptoms and complications of hepatitis C

Symptoms of Hepatitis C

The symptoms of hepatitis C vary dramatically depending on whether the infection is acute or chronic. Many people feel fine at first or for many years. Some notice mild, flu-like symptoms in the early stage. However, most people don’t show any signs. The virus quietly harms the liver over time. That’s why hepatitis C is often called a “silent epidemic.” In many cases, people only learn they have it during a routine check-up or after they develop serious problems like cirrhosis or liver cancer. Early Phase: Acute Hepatitis C Symptoms Acute hepatitis C happens in the first six months after infection. Around 70–80% of people do not feel any symptoms during this time. So, the infection often goes unnoticed. For the few who do get symptoms, these usually start 2 to 12 weeks after exposure. Common signs include: These symptoms may seem like a cold or stomach bug. Often, they go away on their own. In about 15–25% of people, the body fights off the virus without treatment. Still, during this time, the person can pass the virus to others—especially through blood contact. Long-Term Phase: Chronic Hepatitis C Symptoms If the virus stays in the body for more than six months, it becomes chronic hepatitis C. This stage is more dangerous because it lasts for years. The immune system may slow down the virus, but it doesn’t stop it. Over time, the liver becomes inflamed and scarred. This happens slowly and often without symptoms. Most people still feel fine. But as the liver becomes weaker, clearer symptoms may appear. Common General Symptoms Digestive and Stomach Symptoms These signs may seem minor at first. Often, people don’t realize they are liver-related until a blood test shows problems. Signs of Serious Liver Damage from Hepatitis C As liver disease worsens, more noticeable symptoms appear. These signs often show up in people with cirrhosis or liver failure. Jaundice The skin and eyes turn yellow when the liver can’t process waste well. This shows the liver is failing. Swollen Belly (Ascites) Fluid builds up in the belly, causing swelling and pain. This means the liver is under serious stress. Doctors may drain the fluid or give medicine to help. Bleeding from the Stomach or Throat As cirrhosis worsens, pressure in the liver veins rises. This causes veins in the throat or stomach to swell and bleed. This can be life-threatening. Hepatic Encephalopathy The liver can no longer remove toxins from the blood. This causes brain problems such as: Muscle Loss and Weight Drop The body burns muscle when the liver stops working well. Chronic inflammation also leads to weight loss. When Hepatitis C Affects the Skin and Body Hepatitis C sometimes causes problems outside the liver. These are called extrahepatic symptoms, and they can be the first signs of infection. Common issues include: These issues can happen even if the liver is not badly damaged. Doctors may test for hepatitis C if these signs appear, especially in high-risk groups or people with a history of Hepatitis A. Hepatitis A and Liver Cancer Risk in Hepatitis C Chronic hepatitis C can raise the risk of liver cancer, called hepatocellular carcinoma (HCC). These symptoms usually don’t appear until the cancer is advanced. Warning signs may include: People with cirrhosis need regular check-ups every six months. Ultrasound is often used to catch liver cancer early, when it is still treatable. Hepatitis A and Mental Health in Hepatitis C Hepatitis C doesn’t just affect the body—it affects how people feel emotionally, too. Even without strong physical symptoms, mental and social stress is common. Many people face: These struggles can grow worse with tiredness, money issues, or poor access to care. In some cases, having other infections like Hepatitis A adds to the stress. Support from doctors, mental health workers, and community groups can make a big difference. In Summary The symptoms of hepatitis C range from silent to severe. Most people do not feel sick during the early or even middle stages. But the liver may still be getting damaged the whole time. By the time symptoms do appear, the damage can be serious. That’s why it’s so important to screen people at risk—especially if they’ve had other infections like Hepatitis A. Early diagnosis leads to quick treatment, and modern medicine can now cure the virus in most people before long-term damage sets in. [Next: Treatment of Hepatitis C →]

Symptoms of Hepatitis C Read More »

Medical syringe and vial labelled Hepatitis C vaccine held by gloved hand

Treatment of Hepatitis C

The treatment of hepatitis C has undergone a remarkable transformation over the past two decades, moving from toxic, low-success therapies to highly effective, well-tolerated cures. Now, most people with hepatitis C can be cured by taking pills for just a few weeks. The goal is no longer just to manage the virus. Today, doctors aim to remove the virus completely. This helps prevent liver failure, cirrhosis, and liver cancer. When to Start Hepatitis C Treatment Almost all adults with chronic hepatitis C can and should start treatment. This includes people with no or mild liver damage. The only exception may be those with a very short life expectancy from other illnesses. In the past, older treatments caused harsh side effects and worked less often. That is no longer a concern with modern medication. Reasons to treat hepatitis C early include: Modern Medications: Direct-Acting Antivirals (DAAs) The main drugs used to treat hepatitis C today are called direct-acting antivirals (DAAs). These medicines stop the virus from growing. They are much easier to take than older drugs. DAAs: Common DAA Combinations a) Sofosbuvir + Velpatasvir (brand: Epclusa)This works for all hepatitis C types. Doctors use it for both new and previously treated patients. b) Glecaprevir + Pibrentasvir (brand: Mavyret)This also treats all virus types. It is often used for shorter, 8-week treatments. It works well even if the person has mild cirrhosis or had past treatment. c) Sofosbuvir + Ledipasvir (brand: Harvoni)This is especially helpful for genotype 1. It is approved for adults, teens, and children. Doctors choose the right combination based on: Monitoring During and After Treatment Even though DAAs are simple to use, some tests are still needed. Before starting treatment, doctors usually check: During treatment, a basic blood test is done after 4 weeks to check safety. After treatment, a final test 12 weeks later checks if the virus is gone. If the virus stays undetectable, this is called a sustained virologic response (SVR), which means the person is cured and cannot infect others. Special Cases: Co-Infections and Liver Conditions Some people need special care during hepatitis C treatment. Cirrhosis People with cirrhosis may need different drugs. If cirrhosis is severe, a liver specialist should help manage care. Even after being cured, these patients still need regular liver scans to check for cancer. HIV and Hepatitis B People with both HIV and hepatitis C can be cured with DAAs. But doctors must avoid drug conflicts with HIV medicine. People with hepatitis B may have a flare-up during hepatitis C treatment. Doctors monitor this closely and may give extra medicine to prevent problems. Kidney Disease Some DAA drugs are safe for people on dialysis or with weak kidneys. Glecaprevir/pibrentasvir is often used in these cases. Children and Teens DAAs are approved for kids as young as 3. A liver doctor who treats children should guide care. Pregnancy Pregnant women should wait to start treatment. DAAs are not yet approved during pregnancy. Women should use birth control and finish treatment before getting pregnant. Research is underway to change this in the future. Access and Cost of Hepatitis C Treatment In many poorer countries, access to treatment is still a challenge. Cost, health system limits, and low awareness slow down progress. But thanks to cheaper generic drugs and help from global health programs, more people are getting treated. Countries that screen and treat early, and buy drugs in bulk, have seen big drops in liver disease and deaths. Lifestyle Tips During and After Treatment While taking DAAs, patients should make healthy changes to protect their liver: Education and support services make a big difference. This is especially true for people recovering from substance use or those who struggle to understand complex health information. In Summary Treating hepatitis C is now easier and more successful than ever before. New antiviral pills cure most people with few side effects. Even those with other illnesses or advanced liver damage can benefit. Early treatment, good follow-up, and lifestyle changes help people live longer, healthier lives. Wider access and better screening will help stop the spread of hepatitis C—and prevent co-infections like Hepatitis A from making things worse. The future of hepatitis C care is hopeful, thanks to science, support, and smart public health action. [Next: Complications of Hepatitis C →]

Treatment of Hepatitis C Read More »

Scroll to Top